Literature DB >> 25317615

Prevalence of anxiety and depression and its comorbidities in patients with chronic kidney disease on hemodialysis and peritoneal dialysis.

Camila Edith Stachera Stasiak1, Kalyl Singh Bazan1, Renata Stoeberl Kuss2, Adriana Fatima Menegat Schuinski1, Gilberto Baroni1.   

Abstract

INTRODUCTION: Patients with chronic kidney disease (CKD) who perform renal replacement therapy (RRT) are subject to a higher prevalence of mood disorders.
OBJECTIVE: The aim of this study is to compare the prevalence of anxiety and depression in patients on hemodialysis (HD) and peritoneal dialysis (PD), taking into account comorbidities that may contribute to this.
METHODS: The study was done in Ponta Grossa with CKD patients, using Beck Depression and Anxiety Inventory (BDI and BAI) and the Hospital Anxiety and Depression Scale (HADS).
RESULTS: We studied 155 patients, 128 in the HD group and 27 in PD. In the first, depression was found in 22.6% of patients in the BDI and 9.3% in HADS, and anxiety 25.7% in the BAI and 11.7% in the HADS. In the PD group, 29.6% of patients had depression in the BDI and 14.8% in HADS, and anxiety 11.1% in the BAI and none in HADS.
CONCLUSION: The hemodialysis or peritoneal dialysis did not influence the prevalence of anxiety and depression in patients with CKD.

Entities:  

Mesh:

Year:  2014        PMID: 25317615     DOI: 10.5935/0101-2800.20140047

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN: 0101-2800


  15 in total

1.  Indicators and correlates of psychological disturbance in Chinese patients receiving maintenance hemodialysis: a cross-sectional study.

Authors:  Si-Yuan Wang; Xiao-Ying Zang; Jun-Duo Liu; Mei Cheng; Yue-Xian Shi; Yue Zhao
Journal:  Int Urol Nephrol       Date:  2015-01-28       Impact factor: 2.370

2.  Quality of life of individuals with chronic kidney disease on dialysis.

Authors:  Nadaby Maria Jesus; Gracielly Ferreira de Souza; Clesnan Mendes-Rodrigues; Omar Pereira de Almeida Neto; Deusdélia Dias Magalhães Rodrigues; Cristiane Martins Cunha
Journal:  J Bras Nefrol       Date:  2019-01-24

3.  Prevalence of Mental Disorders in a German Kidney Transplant Population: Results of a KTx360°-Substudy.

Authors:  Katrin Birkefeld; Maximilian Bauer-Hohmann; Felix Klewitz; Eva-Marie Kyaw Tha Tun; Uwe Tegtbur; Lars Pape; Lena Schiffer; Mario Schiffer; Martina de Zwaan; Mariel Nöhre
Journal:  J Clin Psychol Med Settings       Date:  2022-02-23

4.  Depression Among Hemodialysis Patients: Related Factors and the Impact of Insomnia and Fatigue.

Authors:  Jona Sakiqi; Georgios Vasilopoulos; Ioannis Koutelekos; Maria Polikandrioti; Evangelos Dousis; Niki Pavlatou; Antonia Kalogianni; Stavros Tsirigotis; Georgia Gerogianni
Journal:  Cureus       Date:  2022-05-23

5.  Potential Depression and Associated Factors Among Individuals Undergoing Dialysis: A Hospital-Based Cross-Sectional Survey in Central Kerala.

Authors:  K R Neenumol; Jissa V Thulaseedharan
Journal:  Indian J Nephrol       Date:  2022-01-05

6.  The role of socio-demographic factors in depression and anxiety of patients on hemodialysis: an observational cross-sectional study.

Authors:  G Gerogianni; E Lianos; A Kouzoupis; M Polikandrioti; E Grapsa
Journal:  Int Urol Nephrol       Date:  2017-11-20       Impact factor: 2.370

Review 7.  A holistic approach to factors affecting depression in haemodialysis patients.

Authors:  Georgia Gerogianni; Anastasios Kouzoupis; Eirini Grapsa
Journal:  Int Urol Nephrol       Date:  2018-05-19       Impact factor: 2.370

8.  EFFECT OF PERCEIVED SOCIAL SUPPORT ON THE LEVELS OF ANXIETY AND DEPRESSION OF HEMODIALYSIS PATIENTS.

Authors:  Ioanna Lilympaki; Andriana Makri; Kyriaki Vlantousi; Ioannis Koutelekos; Fotoula Babatsikou; Maria Polikandrioti
Journal:  Mater Sociomed       Date:  2016-10-17

9.  Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease.

Authors:  Jian-Wei Chen; Shu-Qin Xie
Journal:  Neuropsychiatr Dis Treat       Date:  2018-02-16       Impact factor: 2.570

10.  Design and protocol for the Dialysis Optimal Health Program (DOHP) randomised controlled trial.

Authors:  Simon R Knowles; Chantal F Ski; Robyn Langham; Emmet O'Flaherty; David R Thompson; Susan L Rossell; Gaye Moore; Ya-Seng Arthur Hsueh; David J Castle
Journal:  Trials       Date:  2016-09-09       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.